High-mobility group box 1 fragment suppresses adverse post-infarction remodeling by recruiting PDGFRα-positive bone marrow cells. PLoS One. 2020;15(4):e0230392..
Noninvasive OCT Imaging of Three-Dimensional Cardiac Tissues Derived from Human Induced Pluripotent Stem Cells. J Tissue Eng Regen Med. 2020..
CXCL4/PF4 is a predictive biomarker of cardiac differentiation potential of human induced pluripotent stem cells. Sci Rep. 2019;9(1):4638.
Laminin-511 Supplementation Enhances Stem Cell Localization with Suppression in the Decline of Cardiac Function in Acute Infarct Rats. Transplantation. 2019..
MHC-mismatched Allotransplantation of Induced Pluripotent Stem Cell-Derived Cardiomyocyte Sheets to Improve Cardiac Function in A Primate Ischemic Cardiomyopathy Model. Transplantation. 2019.
The administration of high-mobility group box 1 fragment prevents deterioration of cardiac performance by enhancement of bone marrow mesenchymal stem cell homing in the delta-sarcoglycan-deficient hamster. PLoS One. 2018;13(12):e0202838..
Building a new strategy for treating heart failure using Induced Pluripotent Stem Cells. J Cardiol. 2018..
Cell Spray Transplantation of Adipose-Derived Mesenchymal Stem Cell Recovers Ischemic Cardiomyopathy in a Porcine Model. Transplantation. 2018.
Generation of Fabry cardiomyopathy model for drug screening using induced pluripotent stem cell-derived cardiomyocytes from a female Fabry patient. J Mol Cell Cardiol. 2018.
Functional and Electrical Integration of Induced Pluripotent Stem Cell-Derived Cardiomyocytes in a Myocardial Infarction Rat Heart. Cell Transplant. 2015.
N-Glycans: Phenotypic Homology and Structural Differences between Myocardial Cells and Induced Pluripotent Stem Cell-Derived Cardiomyocytes. PLoS One. 2014;9(10):e111064.
Regulating ES or Induced Pluripotent Stem Cells by Innate Lymphoid Cells. Transplantation. 2014;98(5):e38-e39..
Present and Future Perspectives on Cell Sheet-Based Myocardial Regeneration Therapy. Biomed Res Int. 2013;2013:583912..